SECRETION OF SOLUBLE FACTORS BY AML CELLS INFLUENCE CD33/CD3 BITE® ANTIBODY MEDIATED CYTOTOXICITY AND T-CELL PROLIFERATION

被引：0
|
作者：
Costanzi, M. [1 ,2 ]
Krupka, C. [1 ,2 ]
Kischel, R. [3 ]
Kufer, P. [3 ]
Koehnke, T. [1 ,2 ]
Spiekermann, K. [2 ,4 ,5 ]
Hiddemann, W. [2 ,4 ,5 ]
Subklewe, M. [1 ,2 ,4 ,5 ]
机构：
[1] Hosp Ludwig Maximilians Univ LMU, Gene Ctr, Lab Translat Canc Immunol, Munich, Germany
[2] Hosp Ludwig Maximilians Univ LMU, Dept Internal Med 3, Munich, Germany
[3] AMGEN Res GmbH, Munich, Germany
[4] German Canc Consortium DKTK, Heidelberg, Germany
[5] German Canc Res Ctr, Heidelberg, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E867
引用
收藏
页码：357 / 358
页数：2
相关论文
共 50 条
  • [1] Characterization of covariables modulating CD33/CD3 BITE antibody construct mediated cytotoxicity against primary AML cells
    Krupka, Christina
    Kufer, Peter
    Kischel, Roman
    Zugmaier, Gerhard
    Koehnke, Thomas
    Lichtenegger, Felix
    Altmann, Torben
    Spiekermann, Karsten
    Vick, Binje
    Jeremias, Irmela
    Hiddemann, Wolfgang
    Riethmueller, Gert
    Subklewe, Marion
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [2] Hydroxyurea Is Most Suitable for Cytoreduction of AML Prior to CD33/CD3 Bispecific BiTE® Antibody (AMG 330) Therapy: Uncompromised T-Cell Proliferation Ex-Vivo and CD33 Upregulation on AML Cells
    Krupka, Christina
    Brauneck, Franziska
    Lichtenegger, Felix S.
    Kufer, Peter
    Kischel, Roman
    Zugmaier, Gerhard
    Khnke, Thomas
    Altmann, Torben
    Schneider, Stephanie
    Fiegl, Michael
    Spiekermann, Karsten
    Sinclair, Angus M.
    Newhall, Kathryn J.
    Frankel, Stanley R.
    Baeuerle, Patrick
    Hiddemann, Wolfgang
    Riethmueller, Gert
    Subklewe, Marion
    BLOOD, 2014, 124 (21)
  • [3] T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330
    G S Laszlo
    C J Gudgeon
    K H Harrington
    R B Walter
    Blood Cancer Journal, 2015, 5 : e340 - e340
  • [4] T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330
    Laszlo, G. S.
    Gudgeon, C. J.
    Harrington, K. H.
    Walter, R. B.
    BLOOD CANCER JOURNAL, 2015, 5 : e340 - e340
  • [5] Identifying Immune Resistance Mechanisms to CD33/CD3 BiTE® Antibody Construct (AMG 330) Mediated Cytotoxicity
    Krupka, Christina
    Koehnke, Thomas
    Kufer, Peter
    Kischel, Roman
    Lichtenegger, Felix S.
    Brauneck, Franziska
    Rohling, Stefan
    Altmann, Torben
    Hiddemann, Wolfgang
    Subklewe, Marion S.
    BLOOD, 2015, 126 (23)
  • [6] Impact of p53 Knock-Down on T-Cell Proliferation and T-Cell Mediated Cytotoxicity Against AML Cell Lines Mediated By a CD33 Specific BiTE® Antibody Construct
    Pawlowsky, Lea
    Brauchle, Bettina
    Pasikhani, Maryam Kazerani
    Wagner, Ana Ogrinc
    Bucklein, Veit
    Lichtenegger, Felix S.
    Kischel, Roman
    Metzeler, Klaus H.
    Spiekermann, Karsten
    Andreeff, Michael
    Daver, Naval G.
    von Bergwelt, Michael
    Subklewe, Marion
    BLOOD, 2019, 134
  • [7] Evaluation Of CD33 Expression and Functional Analysis Of The CD33/CD3 Bispecific BiTE® Antibody AMG 330 In Primary AML Samples
    Krupka, Christina
    Kufer, Peter
    Kischel, Roman
    Zugmaier, Gerhard
    Boegeholz, Jan
    Koehnke, Thomas
    Lichtenegger, Felix S.
    Schneider, Stephanie
    Metzeler, Klaus H.
    Fiegl, Michael
    Spiekermann, Karsten
    Baeuerle, Patrick
    Hiddemann, Wolfgang
    Riethmueller, Gert
    Subklewe, Marion
    BLOOD, 2013, 122 (21)
  • [8] TARGETING LEUKEMIC STEM CELLS IN AML USING THE BISPECIFIC CD33/CD3 BITE® ANTIBODY AMG 330
    Krupka, C.
    Kufer, P.
    Kischel, R.
    Koehnke, T.
    Zugmaier, G.
    Baeuerle, P.
    Vick, B.
    Konstandin, N.
    Jeremias, I.
    Spiekermann, K.
    Riethmueller, G.
    Hiddemann, W.
    Subklewe, M.
    HAEMATOLOGICA, 2014, 99 : 526 - 526
  • [9] Targeting leukemic stem cells in AML using the Bispecific CD33/CD3 BiTE® antibody AMG 330
    Krupka, C.
    Koehnke, T.
    Lichtenegger, F.
    Altmann, T.
    Vick, B.
    Konstandin, N.
    Metzeler, K.
    Jeremias, I
    Spiekermann, K.
    Riethmueller, G.
    Hiddemann, W.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 114 - 114
  • [10] Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML
    Laszlo, George S.
    Gudgeon, Chelsea J.
    Harrington, Kimberly H.
    Dell'Aringa, Justine
    Newhall, Kathryn J.
    Means, Gary D.
    Sinclair, Angus M.
    Kischel, Roman
    Frankel, Stanley R.
    Walter, Roland B.
    BLOOD, 2014, 123 (04) : 554 - 561
12345